Journal of Oncology

/ Table of Contents: 2022

Table of Contents

Table of Contents: 2022

Journal of Oncology -
Special Issue
Volume 2022
- Article ID 9359879
- Research Article

Role of SERCA3 in the Prognosis and Immune Function in Pan-Cancer

Jiajia Li | Xionghui Li | ... | Yupeng Jiang

Journal of Oncology -
Special Issue
- Volume 2022
- Article ID 7298192
- Research Article

Clinical Study on the Efficacy of Bevacizumab in Combination with Pembrolizumab on Cellular Immune Function in the Treatment of Driver Gene-Negative Stage IV Lung Adenocarcinoma

Jun Gong | Juanjuan Gu | ... | Jianhua Liu

Journal of Oncology -
Special Issue
Volume 2022
- Article ID 3552793
- Research Article

Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress Signals

Keisuke Fukuchi | Kayoko Nanai | ... | Toshinori Agatsuma

Journal of Oncology -
Special Issue
- Volume 2022
- Article ID 1774095
- Research Article

Metformin Suppresses Hepatocellular Carcinoma through Regulating Alternative Splicing of LGR4

Han Zhuo | Shuying Miao | ... | Zhongming Tan

Journal of Oncology -
Special Issue
- Volume 2022
- Article ID 9998114
- Research Article

Effectiveness and Safety of Zercepac and Reference Trastuzumab in the Neoadjuvant Setting for Early-Stage Breast Cancer: A Retrospective Cohort Study

Zheying Liu | Yinan Guan | ... | Tingting Zhu

Journal of Oncology -
Special Issue
- Volume 2022
- Article ID 5821545
- Research Article

SRPX2 Promotes Tumor Proliferation and Migration via the FAK Pathway in Papillary Thyroid Carcinoma

Ning Luo | Yanfei Tan | ... | Chang Liu

Journal of Oncology -
Special Issue
Volume 2022
- Article ID 8594022
- Research Article

Effects of Different Organ Metastases on the Prognosis of Stage IV Urothelial Carcinoma of the Bladder

Liang Liu | Haibo Yuan | ... | Chuangui Li

Journal of Oncology -
Special Issue
Volume 2022
- Article ID 1269435
- Review Article

Sex Disparity in Patients with Gastric Cancer: A Systematic Review and Meta-Analysis

Xiaoyi Luan | Penghui Niu | ... | Yingtai Chen

Journal of Oncology -
Special Issue
Volume 2022
- Article ID 6334546
- Research Article

Lysosomal-Associated Transmembrane Protein 5 Promotes Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma

Ruo-Hui Huang | Zi-Lu Ge | ... | Bin-Bin Zhang

Journal of Oncology -
Special Issue
Volume 2022
- Article ID 9742091
- Review Article

Pulmonary Salivary Gland Tumor, Mucoepidermoid Carcinoma: A Literature Review

Shumin Hu | Jiali Gong | ... | Hongyang Lu

Journal of Oncology -
Special Issue
Volume 2022
- Article ID 7702481
- Research Article

Ultraviolet Radiation Promoted Hypoxia-Induced Apoptosis in HL-60 Human Promyelocytic Leukemia Cell Line

Yilin Wang | Jiandong Sun | ... | Lingzhen Wang

Journal of Oncology -
Special Issue
Volume 2022
- Article ID 7835698
- Research Article

The Role of Ferroptosis-Related Molecules and Significance of Ferroptosis Score in Cervical Cancer

Pengxiang Li | Xuefeng Lv | ... | Dongchun Qin

Journal of Oncology -
Special Issue
Volume 2022
- Article ID 4056398
- Research Article

The Activity of Novel BCR-ABL Small-Molecule Degraders Containing Pyrimidine Rings and Their Role in Overcoming Drug Resistance

Xu Zhang | Linglan Tu | ... | Liyan Cheng

Journal of Oncology -
Special Issue
Volume 2022
- Article ID 5873002
- Research Article

A Lower HCC Incidence in Chronic HBV-Infected Patients Recovered from Acute-on-Chronic Liver Failure: A Prospective Cohort Study

Jianhua Yin | Xiang Xu | ... | Jinhua Hu

Journal of Oncology -
Special Issue
Volume 2022
- Article ID 9636790
- Research Article

A Novel Prognostic Model for Patients with Primary Gastric Diffuse Large B-Cell Lymphoma

Guangrong Lu | Zijian Lin | ... | Jialin Pan

2|3|4|5|6|7|8|9

Evaluate your manuscript with the free Manuscript Language Checker

Author guidelines

Editorial board

Databases and indexing

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.